within Pharmacolibrary.Drugs.ATC.C;

model C01DX10
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00016666666666666666,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01DX10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dilazep is a vasodilator and adenosine reuptake inhibitor, structurally related to dipyridamole. It has been used primarily for cardiovascular diseases such as angina pectoris and has antiplatelet properties. It is not widely approved or used in contemporary Western medicine, but it is used in some Asian countries.</p><h4>Pharmacokinetics</h4><p>No primary PK parameters available in the literature for dilazep in humans. The following estimates are based on analogous vasodilator drugs and basic pharmacokinetic knowledge. Model presumes healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Sambhi, MP, et al., &amp; Gudenzi, M (1989). Therapeutic tolerance, hemodynamic effects, and oral dose kinetics of dilazep dihydrochloride in hypertensive patients. <i>Journal of pharmaceutical sciences</i> 78(4) 281–284. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600780404&quot;>10.1002/jps.2600780404</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2724090/&quot;>https://pubmed.ncbi.nlm.nih.gov/2724090</a></p></li><li><p>Thompson, BR, et al., &amp; Smith, DE (2019). Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice. <i>Biochemical pharmacology</i> 168 57–64. DOI:<a href=&quot;https://doi.org/10.1016/j.bcp.2019.06.013&quot;>10.1016/j.bcp.2019.06.013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31207211/&quot;>https://pubmed.ncbi.nlm.nih.gov/31207211</a></p></li><li><p>Baer, HP, et al., &amp; Van Belle, H (1991). In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters. <i>Naunyn-Schmiedeberg&#x27;s archives of pharmacology</i> 343(4) 365–369. DOI:<a href=&quot;https://doi.org/10.1007/BF00179040&quot;>10.1007/BF00179040</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1852220/&quot;>https://pubmed.ncbi.nlm.nih.gov/1852220</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01DX10;
